USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NANOCYTOMICS, LLC
Address:
1801 MAPLE AVE, STE 4316
EVANSTON, IL 60201-3150
Phone:
N/A
URL:
N/A
EIN:
145103272
DUNS:
967856589
Number of Employees:
4
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $303,215.00 2
SBIR Phase II $1,503,205.00 1
STTR Phase I $300,000.00 1
STTR Phase II $1,508,572.00 1

Award List:

Nanocytological Fecal Assessment to Personalize Colonoscopic Surveillance

Award Year / Program / Phase:
2012 / STTR / Phase I
Award Amount:
$300,000.00
Agency:
HHS
Principal Investigator:
Hemant K. Roy – 617-638-8345
Research Institution:
ITALIAN HOSPITAL
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): The clinical impact of the 5 million annual surveillance colonoscopies (follow up of previous neoplasia) is remarkably low (gt90% without significant neoplasia). Juxtaposed with this is the alarmingly frequent occurrence of colorectal cancers (CRCs) in… More

SBIR Phase I: Partial Wave Spectroscopic (PWS) Microscopy: an early screening for lung cancer

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$149,970.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research Phase I project aims to develop and commercialize a technology that can screen patients who are at risk for lung cancer by means of a simple buccal swab of the cheek epithelium. Lung cancer is the leading cause of cancer deaths in the U.S. The reason for the… More

COLORECTAL CANCER (CRC) SCREENING VIA RECTAL NANOCYTOLOGY

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$153,245.00
Agency:
HHS
Principal Investigator:
Hariharan Subramanian – 847-467-3216
Abstract:
DESCRIPTION (provided by applicant): The goal of this small business innovation research grant is to develop and commercialize a highly accurate, minimally invasive risk stratification technique for colorectal cancer (CRC) that is simple enough to be performed by the primary care provider during an… More

Nanocytological Fecal Assessment to Personalize Colonoscopic Surveillance

Award Year / Program / Phase:
2013 / STTR / Phase II
Award Amount:
$1,508,572.00
Agency:
HHS
Principal Investigator:
Hemant K. Roy – 617-638-8345
Research Institution:
NORTHSHORE UNIVERSITY HEALTH SYSTEMS
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): The clinical impact of the 5 million annual surveillance colonoscopies (follow up of previous neoplasia) is remarkably low (gt90% without significant neoplasia). Juxtaposed with this is the alarmingly frequent occurrence of colorectal cancers (CRCs) in between… More

COLORECTAL CANCER (CRC) SCREENING VIA RECTAL NANOCYTOLOGY

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,503,205.00
Agency:
HHS
Principal Investigator:
Hariharan Subramanian – 847-467-3216
Abstract:
DESCRIPTION (provided by applicant): The goal of this small business innovation research grant is to develop and commercialize a highly accurate, minimally invasive risk stratification technique for colorectal cancer (CRC) that is simple enough to be performed by the primary care provider during an… More